invivodata’s DiaryPRO Collects Primary Endpoint Data for Phase II Clinical Study

invivodata’s DiaryPRO solution used by patients to report daily pain frequency and severity.

This article is located at another site and will open a new window or tab in your browser. Some links may require Adobe Acrobat Reader. To continue reading, please click here:

http://www.invivodata.com/corp/invivodata_Depomed.htm?print=1

Press Relations Contact

Britney Hamberg

Email: bh@rccf.com

Phone: 513-621-9700

Portfolio Companies

ISD Holdings

Testimonial

EVault

Testimonial

Simbionix

Testimonial

Electronic Data Resources

Testimonial

SciQuest

Testimonial

EndoChoice

Testimonial

Suros Surgical Systems

Testimonial

Stay Updated

Stay connected by subscribing to our quarterly e-newsletter. Get the latest news and updates sent right to your inbox..